Search research articles
Contact Us
Filters
Showing results (1-10 of 77) with videos related to
Page
of 8
Sort By:
Nephrologie & Therapeutique
|
February 22, 2018
P Rossignol, L Juillard
Clinical Pharmacology and Therapeutics
|
July 15, 2017
Impact of Hyperkalemia and Worsening Renal Function on the Use of Renin Angiotensin Aldosterone System Inhibitors in Chronic Heart Failure With Reduced Ejection Fraction
B Pitt, P Rossignol
Journal of Endotoxin Research
|
April 17, 2003
Antagonism of in vivo and ex vivo response to endotoxin by E5564, a synthetic lipid A analogue
Daniel P Rossignol, Melvyn Lynn
Current Opinion in Investigational Drugs (London, England : 2000)
|
May 26, 2005
TLR4 antagonists for endotoxemia and beyond
Daniel P Rossignol, Melvyn Lynn
Mechanisms of Ageing and Development
|
August 1, 1984
Effects of procaine on the oxidative phosphorylation of brain mitochondria from senescent rats
F Bai, R Michel, P Rossignol
Journal of Bacteriology
|
May 1, 1979
Biochemistry of L-proline-triggered germination of Bacillus megaterium spores
D P Rossignol, J C Vary
Diabetes & Metabolism
|
August 8, 2015
Review of heart failure treatment in type 2 diabetes patients: It's at least as effective as in non-diabetic patients!
N Girerd, F Zannad, P Rossignol
Ciba Foundation Symposium
|
January 1, 1983
The molecular basis of sperm-egg interaction in the sea urchin
D P Rossignol, W J Lennarz
Psychopharmacology
|
January 1, 1989
Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors
V Daugé, P Rossignol, B P Roques
Psychopharmacology
|
January 1, 1988
Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective mu and delta opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes
V Daugé, P Rossignol, B P Roques
Page
of 8
Search research articles
Search
Showing results (1-10 of 77) with videos related to
Sort By:
Page
of 8
Nephrologie & Therapeutique
|
February 22, 2018
P Rossignol, L Juillard
Clinical Pharmacology and Therapeutics
|
July 15, 2017
Impact of Hyperkalemia and Worsening Renal Function on the Use of Renin Angiotensin Aldosterone System Inhibitors in Chronic Heart Failure With Reduced Ejection Fraction
B Pitt, P Rossignol
Journal of Endotoxin Research
|
April 17, 2003
Antagonism of in vivo and ex vivo response to endotoxin by E5564, a synthetic lipid A analogue
Daniel P Rossignol, Melvyn Lynn
Current Opinion in Investigational Drugs (London, England : 2000)
|
May 26, 2005
TLR4 antagonists for endotoxemia and beyond
Daniel P Rossignol, Melvyn Lynn
Mechanisms of Ageing and Development
|
August 1, 1984
Effects of procaine on the oxidative phosphorylation of brain mitochondria from senescent rats
F Bai, R Michel, P Rossignol
Journal of Bacteriology
|
May 1, 1979
Biochemistry of L-proline-triggered germination of Bacillus megaterium spores
D P Rossignol, J C Vary
Diabetes & Metabolism
|
August 8, 2015
Review of heart failure treatment in type 2 diabetes patients: It's at least as effective as in non-diabetic patients!
N Girerd, F Zannad, P Rossignol
Ciba Foundation Symposium
|
January 1, 1983
The molecular basis of sperm-egg interaction in the sea urchin
D P Rossignol, W J Lennarz
Psychopharmacology
|
January 1, 1989
Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors
V Daugé, P Rossignol, B P Roques
Psychopharmacology
|
January 1, 1988
Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective mu and delta opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes
V Daugé, P Rossignol, B P Roques
Page
of 8